Jianhong Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jianhong Zhao has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Shuyan Li
School of Medical Information and Engineering, Xuzhou Medical University, Xuzhou, China
3 shared publications - E Yu
National Demonstration Centre for Experimental Chemistry Education, Lanzhou University, Lanzhou, China
2 shared publications - Hengxue Shi
College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, China
2 shared publications - Jiangpeng Wu
Lanzhou University
2 shared publications - Jing Fan
College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, China
2 shared publications - Liping Gao
Department of Pneumology, Lanzhou University Second Hospital, Lanzhou, China
2 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 14, e78523
Automated Renal Tumor Segmentation in Computed Tomography Images Using a Global Attention–Based DeepLabV3+ Model: Algorithm Development and Validation
Background: The rising global incidence of renal tumors necessitates precise diagnostic interventions. Accurate segmentation of computed tomography (CT) scans is essential for nephron-sparing surgery and radiotherapy. However, conventional manual delineation is labor-intensive and prone to significant interobserver variability due to tumor morphological heterogeneity. There is an urgent clinical demand for robust, automated segmentation solutions. Objective: This study aims to develop and validate GAM-DeepLabV3+, an automated framework designed to address boundary ambiguity and high false-positive rates in complex renal imaging scenarios. Methods: We propose an optimized encoder-decoder architecture specifically tailored for renal mass detection. The framework incorporates three key innovations: (1) a lightweight MobileNetV2 backbone to minimize computational overhead for clinical deployment; (2) an Atrous Spatial Pyramid Pooling (ASPP) module to capture multiscale contextual information; and (3) a Global Attention Mechanism (GAM) in the decoder to enhance channel-spatial interactions, thereby refining boundary delineation by suppressing background noise. The model was rigorously evaluated on a private clinical dataset (n=218) and the KiTS19 benchmark (n=210). Results: GAM-DeepLabV3+ consistently outperformed state-of-the-art baselines. On the private dataset, the model achieved a mean Dice similarity coefficient (DSC) of 0.939 (SD 0.008), significantly surpassing feature pyramid network (FPN; mean 0.893, SD 0.008; P <.001) and no-new-Net (nnU-Net; 2D, custom; mean 0.908, SD 0.013; P <.001). It also achieved a mean 95% Hausdorff distance (HD95) of 1.485 (SD 0.522) pixels. On the KiTS19 dataset, it maintained a mean robust DSC of 0.928 (SD 0.006). To facilitate clinical translation, a demonstration-only online platform was developed. Conclusions: The GAM-DeepLabV3+ framework provides an accurate, efficient, and fully automated solution for renal tumor segmentation. By overcoming boundary ambiguity and optimizing feature fusion, this approach shows potential as a decision-support aid, pending future validation with 3D reconstruction.
- 15 September 2026
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 14, e78523
Open AccessAutomated Renal Tumor Segmentation in Computed Tomography Images Using a Global Attention–Based DeepLabV3+ Model: Algorithm Development and Validation
Background: The rising global incidence of renal tumors necessitates precise diagnostic interventions. Accurate segmentation of computed tomography (CT) scans is essential for nephron-sparing surgery and radiotherapy. However, conventional manual delineation is labor-intensive and prone to significant interobserver variability due to tumor morphological heterogeneity. There is an urgent clinical demand for robust, automated segmentation solutions. Objective: This study aims to develop and validate GAM-DeepLabV3+, an automated framework designed to address boundary ambiguity and high false-positive rates in complex renal imaging scenarios. Methods: We propose an optimized encoder-decoder architecture specifically tailored for renal mass detection. The framework incorporates three key innovations: (1) a lightweight MobileNetV2 backbone to minimize computational overhead for clinical deployment; (2) an Atrous Spatial Pyramid Pooling (ASPP) module to capture multiscale contextual information; and (3) a Global Attention Mechanism (GAM) in the decoder to enhance channel-spatial interactions, thereby refining boundary delineation by suppressing background noise. The model was rigorously evaluated on a private clinical dataset (n=218) and the KiTS19 benchmark (n=210). Results: GAM-DeepLabV3+ consistently outperformed state-of-the-art baselines. On the private dataset, the model achieved a mean Dice similarity coefficient (DSC) of 0.939 (SD 0.008), significantly surpassing feature pyramid network (FPN; mean 0.893, SD 0.008; P <.001) and no-new-Net (nnU-Net; 2D, custom; mean 0.908, SD 0.013; P <.001). It also achieved a mean 95% Hausdorff distance (HD95) of 1.485 (SD 0.522) pixels. On the KiTS19 dataset, it maintained a mean robust DSC of 0.928 (SD 0.006). To facilitate clinical translation, a demonstration-only online platform was developed. Conclusions: The GAM-DeepLabV3+ framework provides an accurate, efficient, and fully automated solution for renal tumor segmentation. By overcoming boundary ambiguity and optimizing feature fusion, this approach shows potential as a decision-support aid, pending future validation with 3D reconstruction.
- Open Access
- 15 August 2019
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 7 (3) , e13476
A Machine Learning Method for Identifying Lung Cancer Based on Routine Blood Indices: Qualitative Feasibility Study
Background: Liquid biopsies based on blood samples have been widely accepted as a diagnostic and monitoring tool for cancers, but extremely high sensitivity is frequently needed due to the very low levels of the specially selected DNA, RNA, or protein biomarkers that are released into blood. However, routine blood indices tests are frequently ordered by physicians, as they are easy to perform and are cost effective. In addition, machine learning is broadly accepted for its ability to decipher complicated connections between multiple sets of test data and diseases. Objective: The aim of this study is to discover the potential association between lung cancer and routine blood indices and thereby help clinicians and patients to identify lung cancer based on these routine tests. Methods: The machine learning method known as Random Forest was adopted to build an identification model between routine blood indices and lung cancer that would determine if they were potentially linked. Ten-fold cross-validation and further tests were utilized to evaluate the reliability of the identification model. Results: In total, 277 patients with 49 types of routine blood indices were included in this study, including 183 patients with lung cancer and 94 patients without lung cancer. Throughout the course of the study, there was correlation found between the combination of 19 types of routine blood indices and lung cancer. Lung cancer patients could be identified from other patients, especially those with tuberculosis (which usually has similar clinical symptoms to lung cancer), with a sensitivity, specificity and total accuracy of 96.3%, 94.97% and 95.7% for the cross-validation results, respectively. This identification method is called the routine blood indices model for lung cancer, and it promises to be of help as a tool for both clinicians and patients for the identification of lung cancer based on routine blood indices. Conclusions: Lung cancer can be identified based on the combination of 19 types of routine blood indices, which implies that artificial intelligence can find the connections between a disease and the fundamental indices of blood, which could reduce the necessity of costly, elaborate blood test techniques for this purpose. It may also be possible that the combination of multiple indices obtained from routine blood tests may be connected to other diseases as well.
- 15 August 2019
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 7 (3) , e13476
Open AccessA Machine Learning Method for Identifying Lung Cancer Based on Routine Blood Indices: Qualitative Feasibility Study
Background: Liquid biopsies based on blood samples have been widely accepted as a diagnostic and monitoring tool for cancers, but extremely high sensitivity is frequently needed due to the very low levels of the specially selected DNA, RNA, or protein biomarkers that are released into blood. However, routine blood indices tests are frequently ordered by physicians, as they are easy to perform and are cost effective. In addition, machine learning is broadly accepted for its ability to decipher complicated connections between multiple sets of test data and diseases. Objective: The aim of this study is to discover the potential association between lung cancer and routine blood indices and thereby help clinicians and patients to identify lung cancer based on these routine tests. Methods: The machine learning method known as Random Forest was adopted to build an identification model between routine blood indices and lung cancer that would determine if they were potentially linked. Ten-fold cross-validation and further tests were utilized to evaluate the reliability of the identification model. Results: In total, 277 patients with 49 types of routine blood indices were included in this study, including 183 patients with lung cancer and 94 patients without lung cancer. Throughout the course of the study, there was correlation found between the combination of 19 types of routine blood indices and lung cancer. Lung cancer patients could be identified from other patients, especially those with tuberculosis (which usually has similar clinical symptoms to lung cancer), with a sensitivity, specificity and total accuracy of 96.3%, 94.97% and 95.7% for the cross-validation results, respectively. This identification method is called the routine blood indices model for lung cancer, and it promises to be of help as a tool for both clinicians and patients for the identification of lung cancer based on routine blood indices. Conclusions: Lung cancer can be identified based on the combination of 19 types of routine blood indices, which implies that artificial intelligence can find the connections between a disease and the fundamental indices of blood, which could reduce the necessity of costly, elaborate blood test techniques for this purpose. It may also be possible that the combination of multiple indices obtained from routine blood tests may be connected to other diseases as well.
- Open Access
- 25 January 2019
- Published by JMIR Publications Inc. in JMIR Preprints
A Machine Learning Method for Identifying Lung Cancer Based on Routine Blood Indices: Qualitative Feasibility Study (Preprint)
BACKGROUND Liquid biopsies based on blood samples have been widely accepted as a diagnostic and monitoring tool for cancers, but extremely high sensitivity is frequently needed due to the very low levels of the specially selected DNA, RNA, or protein biomarkers that are released into blood. However, routine blood indices tests are frequently ordered by physicians, as they are easy to perform and are cost effective. In addition, machine learning is broadly accepted for its ability to decipher complicated connections between multiple sets of test data and diseases. OBJECTIVE The aim of this study is to discover the potential association between lung cancer and routine blood indices and thereby help clinicians and patients to identify lung cancer based on these routine tests. METHODS The machine learning method known as Random Forest was adopted to build an identification model between routine blood indices and lung cancer that would determine if they were potentially linked. Ten-fold cross-validation and further tests were utilized to evaluate the reliability of the identification model. RESULTS In total, 277 patients with 49 types of routine blood indices were included in this study, including 183 patients with lung cancer and 94 patients without lung cancer. Throughout the course of the study, there was correlation found between the combination of 19 types of routine blood indices and lung cancer. Lung cancer patients could be identified from other patients, especially those with tuberculosis (which usually has similar clinical symptoms to lung cancer), with a sensitivity, specificity and total accuracy of 96.3%, 94.97% and 95.7% for the cross-validation results, respectively. This identification method is called the routine blood indices model for lung cancer, and it promises to be of help as a tool for both clinicians and patients for the identification of lung cancer based on routine blood indices. CONCLUSIONS Lung cancer can be identified based on the combination of 19 types of routine blood indices, which implies that artificial intelligence can find the connections between a disease and the fundamental indices of blood, which could reduce the necessity of costly, elaborate blood test techniques for this purpose. It may also be possible that the combination of multiple indices obtained from routine blood tests may be connected to other diseases as well.
- 25 January 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Machine Learning Method for Identifying Lung Cancer Based on Routine Blood Indices: Qualitative Feasibility Study (Preprint)
BACKGROUND Liquid biopsies based on blood samples have been widely accepted as a diagnostic and monitoring tool for cancers, but extremely high sensitivity is frequently needed due to the very low levels of the specially selected DNA, RNA, or protein biomarkers that are released into blood. However, routine blood indices tests are frequently ordered by physicians, as they are easy to perform and are cost effective. In addition, machine learning is broadly accepted for its ability to decipher complicated connections between multiple sets of test data and diseases. OBJECTIVE The aim of this study is to discover the potential association between lung cancer and routine blood indices and thereby help clinicians and patients to identify lung cancer based on these routine tests. METHODS The machine learning method known as Random Forest was adopted to build an identification model between routine blood indices and lung cancer that would determine if they were potentially linked. Ten-fold cross-validation and further tests were utilized to evaluate the reliability of the identification model. RESULTS In total, 277 patients with 49 types of routine blood indices were included in this study, including 183 patients with lung cancer and 94 patients without lung cancer. Throughout the course of the study, there was correlation found between the combination of 19 types of routine blood indices and lung cancer. Lung cancer patients could be identified from other patients, especially those with tuberculosis (which usually has similar clinical symptoms to lung cancer), with a sensitivity, specificity and total accuracy of 96.3%, 94.97% and 95.7% for the cross-validation results, respectively. This identification method is called the routine blood indices model for lung cancer, and it promises to be of help as a tool for both clinicians and patients for the identification of lung cancer based on routine blood indices. CONCLUSIONS Lung cancer can be identified based on the combination of 19 types of routine blood indices, which implies that artificial intelligence can find the connections between a disease and the fundamental indices of blood, which could reduce the necessity of costly, elaborate blood test techniques for this purpose. It may also be possible that the combination of multiple indices obtained from routine blood tests may be connected to other diseases as well.